These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 22475489)

  • 41. The protective effect of crocin on the amyloid fibril formation of Aβ42 peptide in vitro.
    Ghahghaei A; Bathaie SZ; Kheirkhah H; Bahraminejad E
    Cell Mol Biol Lett; 2013 Sep; 18(3):328-39. PubMed ID: 23737042
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The butter flavorant, diacetyl, exacerbates β-amyloid cytotoxicity.
    More SS; Vartak AP; Vince R
    Chem Res Toxicol; 2012 Oct; 25(10):2083-91. PubMed ID: 22731744
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Controlling amyloid-beta peptide(1-42) oligomerization and toxicity by fluorinated nanoparticles.
    Saraiva AM; Cardoso I; Pereira MC; Coelho MA; Saraiva MJ; Möhwald H; Brezesinski G
    Chembiochem; 2010 Sep; 11(13):1905-13. PubMed ID: 20661987
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Xanthene food dye, as a modulator of Alzheimer's disease amyloid-beta peptide aggregation and the associated impaired neuronal cell function.
    Wong HE; Kwon I
    PLoS One; 2011; 6(10):e25752. PubMed ID: 21998691
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Lysophosphatidylcholine modulates fibril formation of amyloid beta peptide.
    Sheikh AM; Nagai A
    FEBS J; 2011 Feb; 278(4):634-42. PubMed ID: 21205198
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Evidence of fibril-like β-sheet structures in a neurotoxic amyloid intermediate of Alzheimer's β-amyloid.
    Chimon S; Shaibat MA; Jones CR; Calero DC; Aizezi B; Ishii Y
    Nat Struct Mol Biol; 2007 Dec; 14(12):1157-64. PubMed ID: 18059284
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Structure inducing ionic liquids-enhancement of alpha helicity in the Abeta(1-40) peptide from Alzheimer's disease.
    Debeljuh N; Barrow CJ; Henderson L; Byrne N
    Chem Commun (Camb); 2011 Jun; 47(22):6371-3. PubMed ID: 21547327
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Key residues for the oligomerization of Aβ42 protein in Alzheimer's disease.
    Ngo S; Guo Z
    Biochem Biophys Res Commun; 2011 Oct; 414(3):512-6. PubMed ID: 21986527
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Characterization of early-stage amyloid aggregates by incorporating extrinsic fluorescence and atomic force microscopy.
    Koh M; Lee H; Lee Y; Lee M
    J Nanosci Nanotechnol; 2014 Nov; 14(11):8386-9. PubMed ID: 25958533
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Globular and protofibrillar aβ aggregates impair neurotransmission by different mechanisms.
    Moreth J; Kroker KS; Schwanzar D; Schnack C; von Arnim CA; Hengerer B; Rosenbrock H; Kussmaul L
    Biochemistry; 2013 Feb; 52(8):1466-76. PubMed ID: 23374097
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Dendrimers reduce toxicity of Aβ 1-28 peptide during aggregation and accelerate fibril formation.
    Klajnert B; Wasiak T; Ionov M; Fernandez-Villamarin M; Sousa-Herves A; Correa J; Riguera R; Fernandez-Megia E
    Nanomedicine; 2012 Nov; 8(8):1372-8. PubMed ID: 22465497
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Targeting the neurotoxic species in Alzheimer's disease: inhibitors of Abeta oligomerization.
    De Felice FG; Vieira MN; Saraiva LM; Figueroa-Villar JD; Garcia-Abreu J; Liu R; Chang L; Klein WL; Ferreira ST
    FASEB J; 2004 Sep; 18(12):1366-72. PubMed ID: 15333579
    [TBL] [Abstract][Full Text] [Related]  

  • 53. An anti-Aβ (amyloid β) single-chain variable fragment prevents amyloid fibril formation and cytotoxicity by withdrawing Aβ oligomers from the amyloid pathway.
    Marín-Argany M; Rivera-Hernández G; Martí J; Villegas S
    Biochem J; 2011 Jul; 437(1):25-34. PubMed ID: 21501114
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Characterization of early stage intermediates in the nucleation phase of Aβ aggregation.
    Zhai J; Lee TH; Small DH; Aguilar MI
    Biochemistry; 2012 Feb; 51(6):1070-8. PubMed ID: 22283417
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A Comparison of Three Fluorophores for the Detection of Amyloid Fibers and Prefibrillar Oligomeric Assemblies. ThT (Thioflavin T); ANS (1-Anilinonaphthalene-8-sulfonic Acid); and bisANS (4,4'-Dianilino-1,1'-binaphthyl-5,5'-disulfonic Acid).
    Younan ND; Viles JH
    Biochemistry; 2015 Jul; 54(28):4297-306. PubMed ID: 26087242
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Conformations and biological activities of amyloid beta peptide 25-35.
    Millucci L; Ghezzi L; Bernardini G; Santucci A
    Curr Protein Pept Sci; 2010 Feb; 11(1):54-67. PubMed ID: 20201807
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Formation of toxic fibrils of Alzheimer's amyloid beta-protein-(1-40) by monosialoganglioside GM1, a neuronal membrane component.
    Okada T; Wakabayashi M; Ikeda K; Matsuzaki K
    J Mol Biol; 2007 Aug; 371(2):481-9. PubMed ID: 17582434
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The iAβ5p β-breaker peptide regulates the Aβ(25-35) interaction with lipid bilayers through a cholesterol-mediated mechanism.
    Vitiello G; Grimaldi M; D'Ursi AM; D'Errico G
    Biochem Biophys Res Commun; 2012 Jan; 417(1):88-92. PubMed ID: 22138241
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Mitochondrial Abeta: a potential focal point for neuronal metabolic dysfunction in Alzheimer's disease.
    Caspersen C; Wang N; Yao J; Sosunov A; Chen X; Lustbader JW; Xu HW; Stern D; McKhann G; Yan SD
    FASEB J; 2005 Dec; 19(14):2040-1. PubMed ID: 16210396
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Yeast as a Model for Studies on Aβ Aggregation Toxicity in Alzheimer's Disease, Autophagic Responses, and Drug Screening.
    Porzoor A; Macreadie I
    Methods Mol Biol; 2016; 1303():217-26. PubMed ID: 26235069
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.